Retreatement in patients achie ving response after relapse due to trea tment interruption : results from the crystel study

dc.contributor.authorGriffiths, Gen_US
dc.contributor.authorLuger, Ten_US
dc.contributor.authorBrault, Yen_US
dc.contributor.authorGermain, Jmen_US
dc.contributor.authorMallbris, Len_US
dc.date.accessioned2013-07-13T10:56:03Zen_US
dc.date.available2013-07-13T10:56:03Zen_US
dc.date.issued2013en_US
dc.description.abstractA post hoc analysis of the randomised ; open -label , 54 - week multicentre CRYSTEL study showed pasients who achienved a clinical response ( physi cian global assessmen of psoriasis [PGA]<=2) on etanercept (ETN)50mg twice weekly (BIW) then paused treatement and subsequently relapsed (PGA)>2 were able to recapture the response after retreatement with ETN 25 mg BIW .in clinical practice , however , patient with (PGA <=1 (clear /almost clear ) are more likely to be candidates foren_US
dc.identifier.urihttps://dspace.univ-tlemcen.dz/handle/112/2491en_US
dc.language.isoenen_US
dc.publisherUniversity of Tlemcenen_US
dc.publisherUniversity of Tlemcenen_US
dc.titleRetreatement in patients achie ving response after relapse due to trea tment interruption : results from the crystel studyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
retreatement-in--patients-achie-ving-response-after-relapse--due--to-trea-tment-interruption-:-results---from--the-crystel--study.pdf
Size:
112.91 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: